Marshall Wace North America’s UroGen Pharma URGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-10	Closed	–	–	1630
2019 Q1	$0	Sell	10 -397	-98%	–	﹤0.01%	1913
2018 Q4	$18K	Buy	+407	New	+$18K	﹤0.01%	1400